Business

Infosys audit panel finds no wrongdoing by CEO, CFO

Infosys audit panel finds no wrongdoing by CEO, CFO

Bengaluru– Global software major Infosys on Friday said its internal audit committee found no evidence of financial impropriety or executive…
Gold prices jump up 5.5% in first few days of 2020

Gold prices jump up 5.5% in first few days of 2020

Mumbai–Geopolitical tensions and a slower growth rate has led investors rushing for the safe haven of gold, as the yellow…
Key Samsung India executive confirms his departure on Twitter

Key Samsung India executive confirms his departure on Twitter

New Delhi– Putting all speculation to rest, Ranjivjit Singh, Chief Marketing Officer and Senior Vice President, Mobile Business at Samsung…
When Your Passion Works Against You

When Your Passion Works Against You

When Steve Jobs returned to Apple in 1997 after a 12-year absence, the company he co-founded was dispirited, rudderless, and…
Mistry rules out comeback to Tata Sons, hits out at Ratan Tata

Mistry rules out comeback to Tata Sons, hits out at Ratan Tata

New Delhi– Despite the NCLAT ruling in his favour, Cyrus Mistry said on Sunday that he is not pursuing the Tata…
The New Rice War: China eats into big African markets secured by India

The New Rice War: China eats into big African markets secured by India

BY PRAMOD KUMAR JHA New Delhi– As the buyer becomes the seller, India, the largest exporter of rice in the world,…
Artificial Intelligence research hub to come up in Hyderabad

Artificial Intelligence research hub to come up in Hyderabad

Hyderabad–A Centre for Research in Applied Artificial Intelligence (CRiAA), a R&D Park, a Centre of Excellence and other facilities in…
Markets to end 2019 calendar year with a broader move

Markets to end 2019 calendar year with a broader move

BY ARUN KEJRIWAL Markets began the last week of the calendar year on a negative note and lost on three…
Dipal Doshi-Led Entrada Therapeutics Raises $34 Million in New Round of Funding

Dipal Doshi-Led Entrada Therapeutics Raises $34 Million in New Round of Funding

BOSTON–Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, has…
Back to top button
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker